PRIME MEMBER EXCLUSIVE | 3 Months Free Trial

Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
JAMA Medical News cover art

JAMA Medical News

JAMA Medical News

Written by: JAMA Network
Listen for free

Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

    Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected
    Jul 2 2026

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds."

    Related Content:

    • First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds
    Show More Show Less
    6 mins
  • PMOS is the New PCOS

    PMOS is the New PCOS
    Jun 26 2026

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?"

    Related Content:

    • PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?
    Show More Show Less
    6 mins
  • New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

    New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
    Jun 18 2026

    Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more.

    Related Content:

    • A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
    Show More Show Less
    23 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet